For example, genes encoding chromatin regulators involved in pluripotency, OCT4, SOX2, KLF4, NANOG, and LIN28, are rarely mutated, but frequently overexpressed in cancer, thus rendering pharmacologic interventions challenging (87). This evidence concerns the gene NANOG and cancer.